Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

11 treatments under study, led by Anne Monitoring System 2 Sensors Version B

Research Leaders

13 sponsors active, led by Nuovo Ospedale degli Infermi

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (5)

Trial Status

Unknown2
Active Not Recruiting1
Completed1
Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Anne Monitoring System 2 Sensors Version B1
  • Anne Monitoring System 2 Sensors Version C1
  • Scare Ventilator At 201
  • Wave Device1
  • Nostriltraguslength1

Active Sponsors

  • Nuovo Ospedale degli Infermi1
  • University of Alberta1
  • Guilherme Sant'Anna, MD1
  • Luzerner Kantonsspital1
  • Northwestern University1

Top Investigators

Related Conditions

  • Infant Apnea1
  • Preterm Labor1
  • Birth Outcome Adverse1
  • Ecg Electrode Site Reaction1
  • Delivery Problem For Fetus1

Activity Timeline